{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:18:07Z","timestamp":1786997887190,"version":"build-2736575974"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.virol.2023.01.001","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T18:03:46Z","timestamp":1672855426000},"page":"101-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["A method for mapping the linear epitopes targeted by the natural antibody response to Zika virus infection using a VLP platform technology"],"prefix":"10.1016","volume":"579","author":[{"given":"Alexandra","family":"Fowler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth C.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"Pascale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Peabody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven B.","family":"Bradfute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Frietze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5712-4739","authenticated-orcid":false,"given":"Bryce","family":"Chackerian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2023.01.001_bib1","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00405-19","article-title":"Human monoclonal antibodies potently neutralize Zika virus and select for escape mutations on the lateral ridge of the envelope protein","volume":"93","author":"Bailey","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2023.01.001_bib2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bjid.2018.02.005","article-title":"Prevalence of Guillain-Barr\u00e9 syndrome among Zika virus infected cases: a systematic review and meta-analysis","volume":"22","author":"Barbi","year":"2018","journal-title":"Braz. J. Infect. Dis."},{"key":"10.1016\/j.virol.2023.01.001_bib3","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.vaccine.2018.01.056","article-title":"Immunization with phage virus-like particles displaying Zika virus potential B-cell epitopes neutralizes Zika virus infection of monkey kidney cells","volume":"36","author":"Basu","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2023.01.001_bib4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.chom.2010.08.007","article-title":"The human immune response to dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity","volume":"8","author":"Beltramello","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.virol.2023.01.001_bib5","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1128\/JVI.75.8.4002-4007.2001","article-title":"Biophysical characterization and vector-specific antagonist activity of domain III of the tick-borne flavivirus envelope protein","volume":"75","author":"Bhardwaj","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2023.01.001_bib6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1073\/pnas.89.2.461","article-title":"Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins","volume":"89","author":"Broliden","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2023.01.001_bib7","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1016\/j.vaccine.2010.04.049","article-title":"Immunogenic display of diverse peptides, including a broadly cross-type neutralizing human papillomavirus L2 epitope, on virus-like particles of the RNA bacteriophage PP7","volume":"28","author":"Caldeira","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2023.01.001_bib8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jmb.2011.03.072","article-title":"Peptide epitope identification by affinity selection on bacteriophage MS2 virus-like particles","volume":"409","author":"Chackerian","year":"2011","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.virol.2023.01.001_bib9","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.1016\/j.vaccine.2006.05.059","article-title":"Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-\u03b2 without concomitant T cell responses","volume":"24","author":"Chackerian","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2023.01.001_bib10","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.biologicals.2010.07.004","article-title":"Domain III peptides from flavivirus envelope protein are useful antigens for serologic diagnosis and targets for immunization","volume":"38","author":"Ch\u00e1vez","year":"2010","journal-title":"Biologicals"},{"key":"10.1016\/j.virol.2023.01.001_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00654-20","article-title":"Antibodies to variable domain 4 linear epitopes of the <em>Chlamydia trachomatis<\/em> major outer membrane protein are not associated with Chlamydia resolution or reinfection in women","volume":"5","author":"Collar","year":"2020","journal-title":"mSphere"},{"key":"10.1016\/j.virol.2023.01.001_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00654-20","article-title":"Antibodies to variable domain 4 linear epitopes of the Chlamydia trachomatis major outer membrane protein are not associated with Chlamydia resolution or reinfection in women","volume":"5","author":"Collar","year":"2020","journal-title":"mSphere"},{"key":"10.1016\/j.virol.2023.01.001_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004991","article-title":"Humoral immune responses of dengue fever patients using epitope-specific serotype-2 virus-like particle antigens","volume":"4","author":"Crill","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2023.01.001_bib14","doi-asserted-by":"crossref","first-page":"7769","DOI":"10.1128\/JVI.75.16.7769-7773.2001","article-title":"Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells","volume":"75","author":"Crill","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2023.01.001_bib15","doi-asserted-by":"crossref","first-page":"5747","DOI":"10.1016\/j.vaccine.2015.09.044","article-title":"A cholesterol-lowering VLP vaccine that targets PCSK9","volume":"33","author":"Crossey","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2023.01.001_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132560","article-title":"Identification of an immunogenic mimic of a conserved epitope on the plasmodium falciparum blood stage antigen AMA1 using virus-like particle (VLP) peptide display","volume":"10","author":"Crossey","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2023.01.001_bib17","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.chom.2016.04.013","article-title":"Structures of the Zika virus envelope protein and its complex with a flavivirus broadly protective antibody","volume":"19","author":"Dai","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.virol.2023.01.001_bib18","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.chom.2016.04.013","article-title":"Structures of the Zika virus envelope protein and its complex with a flavivirus broadly protective antibody","volume":"19","author":"Dai","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.virol.2023.01.001_bib19","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/iub.1556","article-title":"Molecular basis of antibody-mediated neutralization and protection against flavivirus","volume":"68","author":"Dai","year":"2016","journal-title":"IUBMB Life"},{"key":"10.1016\/j.virol.2023.01.001_bib20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/vaccines6030062","article-title":"Zika virus vaccines: challenges and perspectives","volume":"6","author":"Das Neves Almeida","year":"2018","journal-title":"Vaccines"},{"key":"10.1016\/j.virol.2023.01.001_bib21","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ni.3058","article-title":"A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus","volume":"16","author":"Dejnirattisai","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.virol.2023.01.001_bib22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.virusres.2013.10.022","article-title":"Fine mapping of a linear epitope on EDIII of Japanese encephalitis virus using a novel neutralizing monoclonal antibody","volume":"179","author":"Deng","year":"2014","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2023.01.001_bib23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12985-020-01329-7","article-title":"Role of RNA-binding proteins during the late stages of Flavivirus replication cycle","volume":"17","author":"Diosa-Toro","year":"2020","journal-title":"Virol. J."},{"key":"10.1016\/j.virol.2023.01.001_bib24","doi-asserted-by":"crossref","first-page":"7805","DOI":"10.3390\/ijms23147805","article-title":"New anti-flavivirus fusion loop human antibodies with Zika virus-neutralizing potential","volume":"23","author":"Fran\u00e7a","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.virol.2023.01.001_bib25","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/978-1-4939-9853-1_9","article-title":"Assessing antibody specificity in human serum using deep sequence-coupled biopanning","volume":"2070","author":"Frietze","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.virol.2023.01.001_bib26","volume":"vol. 12","author":"Frietze","year":"2017"},{"key":"10.1016\/j.virol.2023.01.001_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171511","article-title":"Pathogen-specific deep sequence-coupled biopanning: a method for surveying human antibody responses","volume":"12","author":"Frietze","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2023.01.001_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1158\/2326-6066.CIR-15-0165","article-title":"Identification of anti-CA125 antibody responses in ovarian cancer patients by a novel deep sequence-coupled biopanning platform","volume":"4","author":"Frietze","year":"2016","journal-title":"Cancer Immunol Res."},{"key":"10.1016\/j.virol.2023.01.001_bib29","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01485-19","article-title":"Role of Zika virus envelope protein domain III as a target of human neutralizing antibodies","volume":"10","author":"Gallichotte","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.virol.2023.01.001_bib30","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2165\/00063030-200721030-00002","article-title":"Epitope mapping: the first step in developing epitope-based vaccines","volume":"21","author":"Gershoni","year":"2007","journal-title":"BioDrugs"},{"key":"10.1016\/j.virol.2023.01.001_bib31","doi-asserted-by":"crossref","first-page":"6911","DOI":"10.1016\/j.vaccine.2018.10.022","article-title":"Amphiphilic block copolymer delivery of a DNA vaccine against Zika virus","volume":"36","author":"Hraber","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2023.01.001_bib32","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1073\/pnas.82.2.488","article-title":"Rapid and efficient site-specific mutagenesis without phenotypic selection","volume":"82","author":"Kunkel","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2023.01.001_bib33","doi-asserted-by":"crossref","first-page":"6631","DOI":"10.1128\/JVI.00316-08","article-title":"Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II","volume":"82","author":"Lai","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2023.01.001_bib34","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3201\/eid1408.080287","article-title":"Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007","volume":"14","author":"Lanciotti","year":"2008","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.virol.2023.01.001_bib35","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.chom.2016.03.010","article-title":"A mouse model of Zika virus pathogenesis","volume":"19","author":"Lazear","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.virol.2023.01.001_bib36","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1128\/JVI.00002-08","article-title":"Role of nonstructural protein NS2A in flavivirus assembly","volume":"82","author":"Leung","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2023.01.001_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2020-002350","article-title":"The frequency and clinical presentation of Zika virus coinfections: a systematic review","volume":"5","author":"Lobkowicz","year":"2020","journal-title":"BMJ Global Health"},{"key":"10.1016\/j.virol.2023.01.001_bib38","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1073\/pnas.1815432116","article-title":"Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope","volume":"116","author":"Long","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2023.01.001_bib39","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4269\/ajtmh.21-1279","article-title":"Two-year decay of Zika virus neutralizing antibodies in people living in an endemic region in Brazil","volume":"107","author":"Magalhaes","year":"2022","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.virol.2023.01.001_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan8184","article-title":"Neutralizing human monoclonal antibodies prevent Zika virus infection in macaques","volume":"9","author":"Magnani","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.virol.2023.01.001_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-12677-6","article-title":"Oligomeric state of the ZIKV E protein defines protective immune responses","volume":"10","author":"Metz","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virol.2023.01.001_bib42","article-title":"Virus-like particle based vaccines elicit neutralizing antibodies against the HIV-1 fusion peptide","volume":"8","author":"Mogus","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virol.2023.01.001_bib43","article-title":"Long-term protection of rhesus macaques from Zika virus reinfection","volume":"94","author":"Moreno","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2023.01.001_bib44","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nm1240","article-title":"Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus","volume":"11","author":"Oliphant","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2023.01.001_bib45","doi-asserted-by":"crossref","first-page":"11828","DOI":"10.1128\/JVI.00643-07","article-title":"Induction of epitope-specific neutralizing antibodies against West Nile virus","volume":"81","author":"Oliphant","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2023.01.001_bib46","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/1475-2875-13-326","article-title":"A malaria vaccine candidate based on an epitope of the Plasmodium falciparum RH5 protein","volume":"13","author":"Ord","year":"2014","journal-title":"Malar. J."},{"key":"10.1016\/j.virol.2023.01.001_bib47","series-title":"Dengue Virus Antibodies Enhance Zika Virus Infection","author":"Paul","year":"2016"},{"key":"10.1016\/j.virol.2023.01.001_bib48","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/abbi.1997.0312","article-title":"Subunit fusion confers tolerance to peptide insertions in a virus coat protein","volume":"347","author":"Peabody","year":"1997","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.virol.2023.01.001_bib49","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jmb.2008.04.049","article-title":"Immunogenic display of diverse peptides on virus-like particles of RNA phage MS2","volume":"380","author":"Peabody","year":"2008","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.virol.2023.01.001_bib50","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1038\/s41467-019-09914-3","article-title":"Differential human antibody repertoires following Zika infection and the implications for serodiagnostics and disease outcome","volume":"10","author":"Ravichandran","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virol.2023.01.001_bib51","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.cell.2017.04.024","article-title":"Recurrent potent human neutralizing antibodies to Zika virus in Brazil and Mexico","volume":"169","author":"Robbiani","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.virol.2023.01.001_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/emi.2017.87","article-title":"Specific detection of dengue and Zika virus antibodies using envelope proteins with mutations in the conserved fusion loop","volume":"6","author":"Rockstroh","year":"2017","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.virol.2023.01.001_bib53","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature20564","article-title":"Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice","volume":"540","author":"Sapparapu","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.virol.2023.01.001_bib54","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1743-422X-5-27","article-title":"Constancy and diversity in the flavivirus fusion peptide","volume":"5","author":"Seligman","year":"2008","journal-title":"Virol. J."},{"key":"10.1016\/j.virol.2023.01.001_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.str.2018.05.006","article-title":"Refinement and analysis of the mature Zika virus cryo-EM structure at 3.1 A resolution","volume":"26","author":"Sevvana","year":"2018","journal-title":"Structure"},{"key":"10.1016\/j.virol.2023.01.001_bib56","doi-asserted-by":"crossref","first-page":"S935","DOI":"10.1093\/infdis\/jix515","article-title":"Zika virus structure, maturation, and receptors","volume":"216","author":"Sirohi","year":"2017","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2023.01.001_bib57","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/s41590-018-0210-3","article-title":"The immune response against flaviviruses","volume":"19","author":"Slon Campos","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.virol.2023.01.001_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005296","article-title":"Neuropathogenesis of Zika virus in a highly susceptible immunocompetent mouse model after antibody blockade of type I interferon","volume":"11","author":"Smith","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.virol.2023.01.001_bib59","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.aaf8505","article-title":"Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection","volume":"353","author":"Stettler","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.virol.2023.01.001_bib60","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41467-020-14647-9","article-title":"Capsid protein structure in Zika virus reveals the flavivirus assembly process","volume":"11","author":"Tan","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virol.2023.01.001_bib61","doi-asserted-by":"crossref","first-page":"6982","DOI":"10.1128\/JVI.00551-06","article-title":"Isolation and characterization of human monoclonal antibodies from individuals infected with west nile virus","volume":"80","author":"Throsby","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2023.01.001_bib62","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aai8336","article-title":"Molecular determinants of human neutralizing antibodies isolated from a patient infected with Zika virus","volume":"8","author":"Wang","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.virol.2023.01.001_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/v12101114","article-title":"Expansion and refinement of deep sequence-coupled biopanning technology for epitope-specific antibody responses in human serum","volume":"12","author":"Warner","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2023.01.001_bib64","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-016-0223-x","article-title":"Advancement and applications of peptide phage display technology in biomedical science","volume":"23","author":"Wu","year":"2016","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.virol.2023.01.001_bib65","article-title":"Zika virus evades interferon-mediated antiviral response through the co-operation of multiple nonstructural proteins in vitro","volume":"3","author":"Wu","year":"2017","journal-title":"Cell Discov."},{"key":"10.1016\/j.virol.2023.01.001_bib66","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s12250-019-00093-5","article-title":"Development of neutralizing antibodies against Zika virus based on its envelope protein structure","volume":"34","author":"Yang","year":"2019","journal-title":"Virol. Sin."},{"key":"10.1016\/j.virol.2023.01.001_bib67","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93042","article-title":"Delineating antibody recognition against Zika virus during natural infection","volume":"2","author":"Yu","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.virol.2023.01.001_bib68","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2016.07.020","article-title":"Structural basis of Zika virus-specific antibody protection","volume":"166","author":"Zhao","year":"2016","journal-title":"Cell"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682223000016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682223000016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:58:28Z","timestamp":1758589108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682223000016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":68,"alternative-id":["S0042682223000016"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2023.01.001","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A method for mapping the linear epitopes targeted by the natural antibody response to Zika virus infection using a VLP platform technology","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2023.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}